Search Results - "Huang, Gangxiong"
-
1
miR-20a Encoded by the miR-17―92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
Published in Cancer research (Chicago, Ill.) (15-02-2012)“…The ability of osteosarcoma cells to form lung metastases has been inversely correlated to cell surface Fas expression. Downregulation of Fas allows…”
Get full text
Journal Article -
2
miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases
Published in Molecular cancer therapeutics (01-01-2018)“…The metastatic potential of osteosarcoma cells is inversely correlated to cell surface FAS expression. Downregulation of FAS allows osteosarcoma cells to…”
Get full text
Journal Article -
3
Genetically Modified T cells Targeting Interleukin-11 Receptor α-Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
Published in Cancer research (Chicago, Ill.) (01-01-2012)“…The treatment of osteosarcoma pulmonary metastases remains a challenge. T cells genetically modified to express a chimeric antigen receptor (CAR), which…”
Get full text
Journal Article -
4
B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models
Published in Oncoimmunology (01-01-2020)“…The application of chimeric antigen receptor (CAR)-T cell therapy in patients with advanced solid tumors remains a significant challenge. Simultaneously…”
Get full text
Journal Article -
5
Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
Published in Oncoimmunology (03-08-2017)“…There is a crucial need for a new therapeutic approach for osteosarcoma (OS) lung metastasis since this disease remains the main cause of mortality in OS. We…”
Get full text
Journal Article -
6
PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma
Published in Frontiers in molecular biosciences (07-12-2021)“…Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal carcinoma (EC) in China. Although the PD-1 inhibitor pembrolizumab has been…”
Get full text
Journal Article -
7
Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy
Published in JCI insight (25-01-2022)“…Programmed death-1 homolog (PD-1H) is a coinhibitory molecule that negatively regulates T cell-mediated immune responses. In this study, we determined whether…”
Get full text
Journal Article -
8
Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells
Published in Molecular cancer therapeutics (01-05-2007)“…Chemoresistance is a major reason that patients with osteosarcoma fail to achieve a lasting chemotherapy response, and it contributes to disease relapse,…”
Get full text
Journal Article -
9
CAPER‐α alternative splicing regulates the expression of vascular endothelial growth factor165 in Ewing sarcoma cells
Published in Cancer (15-04-2012)“…BACKGROUND: TC‐71 Ewing sarcoma cells overexpress vascular endothelial growth factor (VEGF) with a shift from the 189 to the 165 isoform. METHODS: The effect…”
Get full text
Journal Article -
10
Identification of Residues Important for Ligand Binding of Thromboxane A2 Receptor in the Second Extracellular Loop Using the NMR Experiment-guided Mutagenesis Approach
Published in The Journal of biological chemistry (28-03-2003)“…The second extracellular loop (eLP2) of the thromboxane A 2 receptor (TP) had been proposed to be involved in ligand binding. Through two-dimensional 1 H NMR…”
Get full text
Journal Article -
11
Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle
Published in Human reproduction (Oxford) (01-12-2002)“…BACKGROUND: It was recently discovered that prostacyclin constituted 40–50% of prostaglandins (PG) produced by minced human oviduct. It is well established…”
Get full text
Journal Article -
12
Abstract 1843: Combination therapy targeting Rb/Wee1 kinase pathways for rhabdomyosarcoma treatment
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. New therapeutic strategies are needed particularly for high-risk…”
Get full text
Journal Article -
13
CAPER‐α alternative splicing regulates the expression of vascular endothelial growth factor 165 in Ewing sarcoma cells
Published in Cancer (15-04-2012)“…Abstract BACKGROUND: TC‐71 Ewing sarcoma cells overexpress vascular endothelial growth factor (VEGF) with a shift from the 189 to the 165 isoform. METHODS: The…”
Get full text
Journal Article -
14
Repeat Infusion of CD19-Specific Chimeric Antigen Receptor T-Cell Could Improve the Efficacy with Consistent Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Published in Blood (29-11-2018)“…Background Patients with relapse and/or chemo-refractory (R/R) diffuse large B cell lymphoma (DLBCL) are often fail to conventional therapy and suffer dismal…”
Get full text
Journal Article -
15
Superior Outcomes in Relapsed/Refractory Childhood B-ALL Than Adult Patients with CD19 CAR-T Cell Therapy: A Single-Center Pilot Prospective Study of 23 Patients
Published in Blood (13-11-2019)“…Objective: CD19 CAR-T cell therapy has emerged as a powerful immunotherapy for relapsed/refractory (R/R) B-ALL. The purpose of this study is to compare the…”
Get full text
Journal Article -
16
Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases
Published in Advances in experimental medicine and biology (2014)“…The lungs are the most common site for the metastatic spread of osteosarcoma. Success in using chemotherapy to improve overall survival has reached a plateau…”
Get more information
Journal Article -
17
CAPER-α alternative splicing regulates the expression of VEGF165 in Ewing’s sarcoma cells
Published in Cancer (25-08-2011)Get full text
Journal Article -
18
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt
Published in Oncogenesis (New York, NY) (23-01-2018)“…The oncogenic epidermal growth factor receptor (EGFR) is commonly overexpressed in solid cancers. The tyrosine kinase activity of EGFR has been a major…”
Get full text
Journal Article -
19
Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
Published in Journal for immunotherapy of cancer (04-11-2015)“…BackgroundDespite the ability of NK cells to kill cancer cells, NK cell–based immunotherapy has resulted in limited clinical benefit. This is largely due to…”
Get full text
Journal Article -
20
Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor
Published in Archives of biochemistry and biophysics (15-03-2004)“…The conformation of a constrained peptide mimicking the putative first intracellular domain (iLP1) of thromboxane A(2) receptor (TP) was determined by (1)H 2D…”
Get full text
Journal Article